side effects of hers semaglutide The FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & to yank its new compounded (Wegovy) weight-loss pill from the Hers Weight Loss Review: Does

Additionally, many people are unaware that the doses used in functional medicine are significantly lower than those associated with severe side effects

Wegovy and mental health safety In 2023, reports of suicidal thoughts in people taking GLP-1 receptor agonists (a class of weight loss medications that mimic gut hormones) prompted safety reviews by the European Medicines Agency, the UKs MHRA, and the US Food and Drug Administration

The researchers first identified 69,228 patients with type 2 diabetes and then analyzed the risk of adult-onset seizures among 18,243 adult patients aged 18 or older who were newly prescribed semaglutide, other glucose-lowering agents, or SGLT2 inhibitors (antidiabetic drugs)

mechanism includes slowed gastric emptying